Latest

BCG

Breakthrough in Cancer Gene Therapy: Systemic Immunotherapy Shines in Treating BCG-Refactory NMIBC

Researchers at Sidi Mohamed Ben Abdellah University have made significant strides in treating Bacillus Calmette-Guérin (BCG)-refractory non-muscle-invasive bladder cancer (NMIBC) using systemic immunotherapy. This innovative approach has shown promising results in patients with limited treatment options, providing a new hope for bladder-sparing therapies. Key Takeaways: * The study aims to